RX SAFES INC Inactive Instrument
RX Safes Inc Stock OTC Bulletin Board
Equities
US78348J2042
Electronic Equipment & Parts
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2018 | GeneSYS ID, Inc. cancelled the transaction announced on October 7, 2015 | CI |
| 2017 | GeneSYS ID, Inc. Announces Board Changes | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2014 | 5.76K | Sales 2015 | 51.61K | Capitalization | 3.79M |
|---|---|---|---|---|---|
| Net income 2014 | - | Net income 2015 | -5M | EV / Sales 2014 * | - |
| Net Debt 2014 | 97.19K | Net Debt 2015 | 97.13K | EV / Sales 2015 | 75.3 x |
| P/E ratio 2014 * |
-
| P/E ratio 2015 |
-0.23
x | Employees | - |
| Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 28.76% |
More Fundamentals
* Assessed data
More news
GeneSYS ID, Inc., formerly RX Safes, Inc., offers various secure fingerprint products and solutions for both the professional and consumer healthcare markets. The Company develops, designs, manufactures and sells finger print activated medication safes and other healthcare storage equipment. It offers autonomous fingerprint medical security solutions for controlled substances. Its products and technology address the economic and social impacts of drug diversion, unauthorized access to medications, prescription drug abuse and poor medication adherence. The Company offers its fingerprint interface as a solution for customers to license and integrate into their own products; jointly develops products with original equipment manufacturer partners to deliver security and accountability to their existing product offerings, and offers customized end user add-on solutions for healthcare facilities, among others. Its product pipeline includes Rx DrugSAFE Pro, Rx DrugSAFE IC and others.
Sector
Electronic Equipment & Parts
| 1st Jan change | Capi. | |
|---|---|---|
| -23.60% | 1.59B | |
| +154.21% | 144M | |
| +27.82% | 136M | |
| +22.54% | 83.81M |
